Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-κB Pathway in Mouse Peritoneal Macrophages

American Journal of Chinese Medicine

Volumn 43, Issue 4, 2015, Pages 731-742

  Kim, Dae Seung ^a   Lee, Hyun Ja ^a   Jeon, Yong Deok ^a   Han, Yo Han ^a   Kee, Ji Ye ^a   Kim, Hyun Jeong ^a   Shin, Hyun Ji ^a   Kang, Jongwook ^f   Lee, Beom Su ^f   Kim, Sung Hoon ^f   Kim, Su Jin ^e   Park, Sang Hyun ^d   Choi, Byung Min ^b   Park, Sung Joo ^c   Um, Jae Young ^f   Hong, Seung Heon ^a  

^a Wonkwang University   (South Korea)

^b School of Medicine   (United States)

^c Wonkwang University   (South Korea)

^d Korea Atomic Energy Research Institute   (South Korea)

^e Daegu Haany University   (South Korea)

^f Kyung Hee University   (South Korea)

Author keywords

Inflammation; Macrophage; Mitogen Activated Protein Kinase; Nuclear factor kappa B; Pinene

Indexed keywords

CYCLOOXYGENASE 2; ESSENTIAL OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRITE; PINENE; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; ALPHA-PINENE; ANTIINFLAMMATORY AGENT; LIPOPOLYSACCHARIDE; PTGS2 PROTEIN, MOUSE; TERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE SYSTEM; INFLAMMATION; MALE; MOUSE; MTT ASSAY; NONHUMAN; PERITONEUM MACROPHAGE; ROSEMARY; TREE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CHEMICAL PHENOMENA; DRUG EFFECTS; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; DEPRESSION, CHEMICAL; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR TARGETED THERAPY; MONOTERPENES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938416779     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X15500457     Document Type: Article

References (34)

1. Ajizian, S.J., B.K. English and E.A. Meals. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathway block inducible nitric oxide syn-thase and tumor necrosis factor accumulation in murine macrophages stimulated with lipo-polysaccharide and interferon-gamma. J. Infect. Dis. 179: 939-944, 1999.
2. Bae, G.S., K.C. Park, S.B. Choi, I.J. Jo, M.O. Choi, S.H. Hong, K. Song, H.J. Song and S.J. Park. Protective effects of alpha-pinene in mice with cerulein-induced acute pancreatitis. Life Sci. 91: 866-871, 2012.
3. Baeuerle, P.A. and D. Baltimore. NF-kappa B: Ten years after. Cell 87: 13-20, 1996.
4. Breyer, R.M., C.K. Bagdassarian, S.A. Myers and M.D. Breyer. Prostanoid receptors: Subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41: 661-690, 2001.
5. Chan, E.D. and D.W. Riches. IFN-gamma LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(MAPK) in a mouse macrophage cell line. Am. J. Physiol.-Cell Physiol. 280: C441-C450, 2001.
6. Chang, F., L.S. Steelman, J.T. Lee, J.G. Shelton, P.M. Navolani, W.L. Blalock, R.A. Franklin and J.A. McCubrey. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: Potential targeting for therapeutic intervention. Leukemia 17: 1263-1293, 2003.
7. Dumitru, C.D., J.D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J.H. Lin, C. Patriotis, N.A. Jenkins, N.G. Copeland, G. Kollias and P.N. Tsichlis. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083, 2000.
8. El-Readi, M.Z., H.H. Eid, M.L. Ashour, S.Y. Eid, R.M. Labib, F. Sporer and M. Wink. Variations of the chemical composition and bioactivity of essential oils from leaves and stems of Liquid-ambar styraciflua (Altingiaceae). J. Pharm. Pharmacol. 65: 1653-1663, 2013.
9. Fukumoto, S., K. Hirai, T. Tanihata, Y. Ohmori, D.J. Stuehr and T.A. Hamilton. Excretory/secretory products from plerocercoids of Spirometraerinacei reduce iNOS and chemokine mRNA levels in peritoneal macrophages stimulated with cytokines and/or LPS. Parasite Immunol. 19: 325-332, 1997.
10. Hong, E.J., K.J. Na, I.G. Choi, K.C. Choi and E.B. Jeung. Antibacterial and antifungal effects of essential oils from coniferous trees. Biol. Pharm. Bull. 27: 863-866, 2004.
11. Kaminska, B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754: 253-262, 2005.
12. Karin, M., Z. G. Liu and E. Zandi. AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246, 1997.
13. Kim, J.B., A.R. Han, E.Y. Park, J.Y. Kim, W. Cho, J. Lee, E.K. Seo and K.T. Lee. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by Poncirin through the NF-kappaB inacti-vation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30: 2345-2351, 2007.
14. Kim, M.J., K.W. Yang, S.S. Kim, S.M. Park, K.J. Park, K.S. Kim, Y.H. Choi, K.K. Cho and C.G. Hyun. Chemical composition and anti-inflammation activity of essential oils from Citrus unshiu flower. Nat. Prod. Commun. 9: 727-730, 2014.
15. Kim, S.J., J.Y. Um and J.Y. Lee. Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-B activation in mouse peritoneal macrophages. Am. J. Chin. Med. 39: 171-181, 2011.
16. Lee, J.H., B.K. Lee, J.H. Kim, S.H. Lee and S.K. Hong. Comparison of chemical compositions and antimicrobial activities of essential oils from three conifer trees; Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obusa. J. Microbiol. Biotechnol. 19: 391-396, 2009.
17. Li, Q. and I.M. Verma. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734, 2002.
18. MacMicking, J., Q.W. Xie and C. Nathan. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-330, 1997.
19. Medzhitov, R. and C.A. Janeway Jr. Innate immunity: The virtues of a nonclonal system of recognition. Cell 9: 295-298, 1997.
20. Mercier, B., J. Prost and M. Prost. The essential oil of turpentine and its major volatile fraction (alpha-and beta-pinenes): A review. Int. J. Occup. Med. Environ. Health 22: 331-342, 2009.
21. Moon, P.D., I.S. Choi, J.H. Go, B.J. Lee, S.W. Kang, S. Yoon, S.J. Han, S.Y. Nam, H.A. Oh, N.R. Han, Y.S. Kim, J.S. Kim, M.J. Kim, H.J. Jeong and H.M. Kim. Inhibitory effects of BiR-yuChe-bang on mast cell-mediated allergic reactions and inflammatory cytokines production. Am. J. Chin. Med. 41: 1267-1282, 2013.
22. Morita, I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 68-69: 165-175, 2002.
23. Mudter, J. and M.F. Neurath. IL-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 13: 1016-1023, 2007.
24. Mühlbauer, R.C., A. Lozano, S. Palacio, A. Reinli and R. Felix. Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone 32: 372-380, 2003.
25. Nam, S.Y., C.K. Chung, J.H. Seo, S.Y. Rah, H.M. Kim and H.J. Jeong. The therapeutic efficacy of a-pinene in an experimental mouse model of allergic rhinitis. Int. Immunopharmacol. 23: 273-282, 2014.
26. Narumi, S., J.H. Finke and T.A. Hamilton. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J. Biol. Chem. 265: 7036-7041, 1990.
27. Park, J.Y. and M.H. Pillinger. Interleukin-6 in the pathogenesis of rheumatoid arthritis. Bull. NYU. Hosp. Jt. Dis. 65(Suppl 1): S4-S10, 2007.
28. Park, Y.D., C.H. Ji, D.S. Choi, M.W. Byun and I.Y. Jeong. Biological evaluation of isoegomaketone isolated from Perilla frutescens and its synthetic derivatives as anti-inflammatory agents. Arch. Pharm. Res. 34: 1277-1282, 2011.
29. Popovic, V., S. Petrovic, M. Tomic, R. Stepanovic-Petrovic, A. Micov, M. Pavlovic-Drobac, M. Couladis and M. Niketic. Antinociceptive and anti-edematous activities of the essential oils of two Balkan endemic Laserpitium species. Nat. Prod. Commun. 9: 125-128, 2014.
30. Reinhart, K. and W. Karzai. Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned. Crit. Care. Med. 29(Suppl 7): S121-S125, 2001.
31. Rincon, M. and C.G. Irvin. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int. J. Biol. Sci. 8: 1281-1290, 2012.
32. Simsek, I. TNF inhibitors-new and old agents for rheumatoid arthritis. Bull. NYU. Hosp. Jt. Dis. 68: 204-210, 2010.
33. Stokkers, P.C., L. Camoglio and S.J. van Deventer. Tumor necrosis factor (TNF) in inflammatory bowel disease: Gene polymorphisms, animal models, and potential for anti-TNF therapy. J. Inflamm. 47: 97-103, 1995.
34. Takematsu, H., H. Ozawa, T. Yoshimura, M. Hara, A. Sakakibara, J. Oyama and H. Tagami. Systemic TNF administration in psoriatic patients: A promising therapeutic modality for severe psoriasis. Br. J. Dermatol. 124: 209-210, 1991.